FDA denies Lexicon appeal of drug rejection

Lexicon Pharmaceuticals has failed in its efforts to appeal a rejection from the FDA for its diabetes drug, Zynquista.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news